Neurocrine Biosciences, Inc. Common Stock (NBIX)

$162.8 +1.19%

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-07-14 ESTIMATED

Across 20 earnings reports since Aug 03, 2021, Neurocrine Biosciences, Inc. Common Stock (NBIX) has a clear post-earnings pattern. It moves ±6.57% on average after reporting and finishes higher 50.0% of the time. Its largest post-earnings gain was +8.88% (May 05, 2026) and its largest decline was -18.46% (Feb 06, 2025). The next earnings report is predicted for 2026-07-14 (estimated).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

Avg Abs. Movement

±6.57%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date	Timing	Open	High	Close	Volume	Movement %	SEC Filing
May 05, 2026	☽ POST	$136.05	$137.15	$135.00	126,578	+8.88%	open_in_new
Feb 11, 2026	☽ POST	$136.44	$139.68	$137.37	68,838	-10.48%	open_in_new
Oct 28, 2025	☽ POST	$147.95	$149.85	$147.41	85,593	-6.36%	open_in_new
Jul 30, 2025	☽ POST	$135.18	$137.08	$136.76	73,484	-6.21%	open_in_new
May 05, 2025	☽ POST	$108.47	$111.22	$109.85	108,898	+8.36%	open_in_new
Feb 06, 2025	☽ POST	$151.30	$153.02	$150.46	74,336	-18.46%	open_in_new
Oct 30, 2024	☀ PRE	$126.09	$131.25	$124.37	192,982	+7.07%	open_in_new
Aug 01, 2024	☀ PRE	$150.50	$157.95	$153.03	74,276	+8.27%	open_in_new
May 01, 2024	☀ PRE	$136.07	$145.19	$143.07	96,979	+4.11%	open_in_new
Feb 07, 2024	☀ PRE	$131.33	$141.64	$136.31	73,595	-4.7%	open_in_new
Oct 31, 2023	☀ PRE	$108.22	$111.31	$110.90	67,056	+3.56%	open_in_new
Aug 01, 2023	☀ PRE	$103.78	$104.27	$103.41	63,359	+1.45%	open_in_new
May 03, 2023	☀ PRE	$107.13	$107.98	$98.68	139,129	-4.57%	open_in_new
Feb 06, 2023	☀ PRE	$107.33	$110.13	$105.06	136,850	-4.56%	open_in_new
Nov 01, 2022	☀ PRE	$114.75	$123.43	$119.35	134,380	+3.72%	open_in_new
Aug 04, 2022	☽ POST	$95.12	$96.56	$95.85	39,776	+8.54%	open_in_new
May 04, 2022	☀ PRE	$91.99	$91.99	$88.46	160,128	-0.24%	open_in_new
Feb 11, 2022	☀ PRE	$81.00	$86.33	$85.45	155,468	+7.32%	open_in_new
Nov 01, 2021	☽ POST	$105.59	$107.98	$106.04	51,236	-9.96%	open_in_new
Aug 03, 2021	☽ POST	$95.80	$98.13	$97.59	74,477	-4.5%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.57%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

description SC TO-T/A

1 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260609	open_in_new SEC.gov
4	20260609	open_in_new SEC.gov
4	20260608	open_in_new SEC.gov
144	20260605	open_in_new SEC.gov
4	20260604	open_in_new SEC.gov
4	20260604	open_in_new SEC.gov
144	20260602	open_in_new SEC.gov
4	20260602	open_in_new SEC.gov
4	20260602	open_in_new SEC.gov
144	20260601	open_in_new SEC.gov

Frequently asked about NBIX earnings

When does Neurocrine Biosciences, Inc. Common Stock report earnings next? expand_more

Neurocrine Biosciences, Inc. Common Stock (NBIX)'s next earnings date is estimated for 2026-07-14. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does NBIX stock move after earnings? expand_more

Over 20 reports, NBIX has moved an average of ±6.57% the session after earnings, closing higher 50.0% of the time.

What was NBIX's biggest post-earnings move? expand_more

NBIX's largest post-earnings gain on record was +8.88% on May 05, 2026, and its largest decline was -18.46% on Feb 06, 2025.

Where can I find Neurocrine Biosciences, Inc. Common Stock's SEC filings? expand_more

All of Neurocrine Biosciences, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.